Relmada Therapeutics, Inc. - stock earnings
RLMD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -22.0 million USD | ? USD |
| 2023Q2 | -25.3 million USD | ? USD |
| 2023Q1 | -26.3 million USD | ? USD |
| 2022Q4 | -37.9 million USD | ? USD |
| 2022Q3 | -39.4 million USD | ? USD |
| 2022Q2 | -39.9 million USD | ? USD |
| 2022Q1 | -39.7 million USD | ? USD |
| 2021Q4 | -34.4 million USD | ? USD |
| 2021Q3 | -42.6 million USD | ? USD |
| 2021Q2 | -26.6 million USD | ? USD |
| 2021Q1 | -22.2 million USD | ? USD |
| 2020Q4 | -20.8 million USD | ? USD |
| 2020Q3 | -16.9 million USD | ? USD |
| 2020Q2 | -11.1 million USD | ? USD |
| 2020Q1 | -10.7 million USD | ? USD |
| 2019Q4 | -4.5 million USD | ? USD |
| 2019Q3 | -3.7 million USD | ? USD |
| 2019Q2 | -4.1 million USD | ? USD |
| 2019Q1 | -2.7 million USD | ? USD |
| 2018Q4 | -7.1 million USD | ? USD |
| 2018Q3 | -3.4 million USD | ? USD |
| 2018Q2 | -3.3 million USD | ? USD |
| 2018Q1 | -3.2 million USD | ? USD |
| 2017Q4 | -1.4 million USD | ? USD |
| 2017Q3 | -981686 USD | ? USD |
| 2017Q2 | -1.6 million USD | ? USD |
| 2017Q1 | -2.0 million USD | ? USD |
| 2016Q4 | -1.0 million USD | ? USD |
| 2016Q3 | -1.6 million USD | ? USD |
| 2016Q2 | -3.3 million USD | ? USD |
| 2016Q1 | -1.9 million USD | ? USD |
| 2015Q4 | -2.5 million USD | ? USD |
| 2015Q3 | 4.7 million USD | ? USD |
| 2015Q2 | 6.0 million USD | ? USD |
| 2015Q1 | -2.5 million USD | ? USD |
| 2014Q4 | 5.5 million USD | ? USD |
| 2014Q3 | -29.8 million USD | ? USD |
| 2014Q2 | -27.8 million USD | ? USD |
| 2014Q1 | -3124 USD | 682 USD |
| 2013Q4 | -14374 USD | 1850 USD |
| 2013Q3 | -12364 USD | 1850 USD |
| 2013Q2 | -19485 USD | 634 USD |
| 2013Q1 | -4146 USD | 2346 USD |
| 2012Q4 | -4146 USD | 2346 USD |
| 2012Q3 | -9020 USD | 2149 USD |
| 2012Q2 | -8629 USD | 1515 USD |
| 2012Q1 | -2481 USD | 400 USD |
| 2011Q4 | -503 USD | 6026 USD |
RLMD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -111.6 million USD | ? USD |
| 2022 | -157.0 million USD | ? USD |
| 2021 | -125.8 million USD | ? USD |
| 2020 | -59.5 million USD | ? USD |
| 2019 | -17.3 million USD | ? USD |
| 2018 | -9.0 million USD | ? USD |
| 2017 | -6.3 million USD | ? USD |
| 2016 | -3.0 million USD | ? USD |
| 2015 | -20.8 million USD | ? USD |
| 2014 | -20.8 million USD | ? USD |
| 2013 | -45015 USD | 5129 USD |
| 2012 | -12052 USD | 7941 USD |
RLMD
Price: $3.68
52 week price:
Earnings Per Share: -3.28 USD
P/E Ratio: -1.51
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 144200
Market Capitalization: 146.6 million